AU2002346143A1 - Compositions for nasal administration of insulin - Google Patents

Compositions for nasal administration of insulin

Info

Publication number: AU2002346143A1
Authority: AU; Australia
Prior art keywords: insulin; compositions; nasal administration; nasal; administration
Prior art date: 2001-07-05
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

AU2002346143A

Other versions

AU2002346143B2 (en

Inventor

Takashi Hanafusa

Shunji Haruta

Toshikazu Oki

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Translational Research Ltd

Original Assignee

Translational Research Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-07-05

Filing date

2002-07-03

Publication date

2003-05-22

2002-07-03 Application filed by Translational Research Ltd filed Critical Translational Research Ltd

2002-07-03 Priority claimed from PCT/JP2002/006721 external-priority patent/WO2003004048A1/en

2003-05-22 Publication of AU2002346143A1 publication Critical patent/AU2002346143A1/en

2007-10-04 Application granted granted Critical

2007-10-04 Publication of AU2002346143B2 publication Critical patent/AU2002346143B2/en

2022-07-03 Anticipated expiration legal-status Critical

Status Ceased legal-status Critical Current

Links

NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 title 2
102000004877 Insulin Human genes 0.000 title 1
108090001061 Insulin Proteins 0.000 title 1
229940125396 insulin Drugs 0.000 title 1
239000000203 mixture Substances 0.000 title 1

AU2002346143A 2001-07-05 2002-07-03 Compositions for nasal administration of insulin Ceased AU2002346143B2 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
JP2001204784		2001-07-05
JP2001-204784		2001-07-05
PCT/JP2002/006721 WO2003004048A1 (en)	2001-07-05	2002-07-03	Compositions for nasal administration of insulin

Publications (2)

Publication Number	Publication Date
AU2002346143A1 true AU2002346143A1 (en)	2003-05-22
AU2002346143B2 AU2002346143B2 (en)	2007-10-04

Family

ID=19041200

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2002346143A Ceased AU2002346143B2 (en)	2001-07-05	2002-07-03	Compositions for nasal administration of insulin

Country Status (10)

Country	Link
US (2)	US6906027B2 (en)
EP (1)	EP1413311A4 (en)
JP (1)	JP4721212B2 (en)
KR (1)	KR20030027108A (en)
CN (1)	CN100341567C (en)
AU (1)	AU2002346143B2 (en)
CA (1)	CA2433583A1 (en)
MX (1)	MXPA03005980A (en)
RU (1)	RU2299743C2 (en)
WO (1)	WO2003004048A1 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR20030027108A (en) *	2001-07-05	2003-04-03	트렌스레셔널 리서치 가부시키가이샤	Compositions for nasal administration of insulin
WO2004073729A1 (en) *	2003-02-21	2004-09-02	Translational Research Ltd.	Compositions for nasal administration of drug
CN1758930B (en)	2003-03-27	2010-06-09	株式会社新日本科学	Nasal cavity powder medicament spraying device
JP4922762B2 (en) *	2004-08-10	2012-04-25	株式会社新日本科学	Composition for nasal administration that is fast-acting and capable of high absorption
US7115561B2 (en) *	2004-09-22	2006-10-03	Patterson James A	Medicament composition and method of administration
ES2652415T3 (en) *	2006-12-26	2018-02-02	Shin Nippon Biomedical Laboratories, Ltd.	Preparation for transnasal application
UA90013C2 (en)	2008-03-19	2010-03-25	Давид Анатолійович Нога	Pharmaceutical composition containing insulin and process for the preparation thereof
US9101539B2 (en) *	2009-05-15	2015-08-11	Shin Nippon Biomedical Laboratories, Ltd.	Intranasal pharmaceutical compositions with improved pharmacokinetics
GB2472327B (en) *	2009-07-31	2013-03-13	Shin Nippon Biomedical Lab Ltd	Intranasal granisetron and nasal applicator
PT2964199T (en)	2013-03-04	2020-05-12	Besins Healthcare Lu Sarl	Dry pharmaceutical compositions comprising active agent nanoparticles bound to carrier particles
EP3049059B1 (en) *	2013-09-24	2021-11-03	Satsuma Pharmaceuticals, Inc.	Intranasal dhe formulation for the treatment of headache
US11744967B2 (en)	2017-09-26	2023-09-05	Shin Nippon Biomedical Laboratories, Ltd.	Intranasal delivery devices
WO2019130701A1 (en) *	2017-12-26	2019-07-04	旭化成株式会社	Cellulose powder
US10758532B2 (en)	2018-12-11	2020-09-01	Satsuma Pharmaceuticals, Inc.	Compositions, devices, and methods for treating or preventing headaches
CA3138846A1 (en) *	2019-05-16	2020-11-19	Shin Nippon Biomedical Laboratories, Ltd.	Powder formulation for intranasal administration, and manufacturing method thereof

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS59163313A (en) *	1983-03-09	1984-09-14	Teijin Ltd	Peptide hormone composition for nasal administration
JPS60224616A (en) *	1984-04-24	1985-11-09	Teijin Ltd	Composition for administration through nose
JPS6242888A (en)	1985-08-21	1987-02-24	カシオ計算機株式会社	IC card with solar cell
JP2505430B2 (en)	1986-11-04	1996-06-12	帝人株式会社	Powdery composition for nasal administration containing basic amino acid
JPH0715963B2 (en)	1987-08-31	1995-02-22	松下電器産業株式会社	Semiconductor device
TW402506B (en) *	1993-06-24	2000-08-21	Astra Ab	Therapeutic preparation for inhalation
CZ287945B6 (en) *	1993-09-17	2001-03-14	Novo Nordisk A/S	Insulin derivative and pharmaceutical preparation in which it is comprised and which is intended for treating diabetes mellitus
JP2802488B2 (en) *	1995-02-08	1998-09-24	有限会社ドット	Bioactive peptide composition for nasal absorption
ATE247456T1 (en) *	1996-02-27	2003-09-15	Teijin Ltd	POWDER COMPOSITION FOR NASAL USE
JP3197221B2 (en)	1996-02-27	2001-08-13	帝人株式会社	Powdery nasal composition having improved absorption
AU5305899A (en)	1998-08-26	2000-03-21	Teijin Limited	Powdery pernasal compositions
JP4338313B2 (en)	1998-08-26	2009-10-07	帝人株式会社	Powdered nasal composition
KR20030027108A (en) *	2001-07-05	2003-04-03	트렌스레셔널 리서치 가부시키가이샤	Compositions for nasal administration of insulin

2002
- 2002-07-03 KR KR10-2003-7003165A patent/KR20030027108A/en not_active Ceased
- 2002-07-03 US US10/250,862 patent/US6906027B2/en not_active Expired - Fee Related
- 2002-07-03 WO PCT/JP2002/006721 patent/WO2003004048A1/en not_active Ceased
- 2002-07-03 EP EP02743793A patent/EP1413311A4/en not_active Withdrawn
- 2002-07-03 MX MXPA03005980A patent/MXPA03005980A/en active IP Right Grant
- 2002-07-03 RU RU2004103187/15A patent/RU2299743C2/en not_active IP Right Cessation
- 2002-07-03 CN CNB028045467A patent/CN100341567C/en not_active Expired - Fee Related
- 2002-07-03 JP JP2003510058A patent/JP4721212B2/en not_active Expired - Lifetime
- 2002-07-03 AU AU2002346143A patent/AU2002346143B2/en not_active Ceased
- 2002-07-03 CA CA002433583A patent/CA2433583A1/en not_active Abandoned
2005
- 2005-03-14 US US11/078,292 patent/US20050158250A1/en not_active Abandoned

Publication	Publication Date	Title
IL161214A0 (en)	2004-09-27	Compositions for delivery of drug combinations
AU2002313236A1 (en)	2003-05-15	Medicinal compositions
AU2002248464A1 (en)	2002-09-12	Stabilized insulin formulations
AU2002222118A1 (en)	2002-06-11	Pharmaceutical compositions for inhalation
AU2002363236A1 (en)	2003-05-12	Compounds, pharmaceutical compositions and methods of use therefor
AU2002364508A1 (en)	2003-06-10	Open-celled substrates for drug delivery
IL158862A0 (en)	2004-05-12	An insulin composition for pulmonary administration
AU2002342050A1 (en)	2003-04-22	Anesthesia drug monitor
AU2002335536A1 (en)	2003-07-03	Pyrimidine compound and medicinal composition thereof
AU2002352344A1 (en)	2003-06-10	Medicament delivery assembly
AU2002364893A1 (en)	2003-06-17	Delivery of medicaments to the nail
AU2002346143A1 (en)	2003-05-22	Compositions for nasal administration of insulin
AU2002258221A1 (en)	2003-05-08	Medicinal composition
EP1413311A4 (en)	2005-10-19	Compositions for nasal administration of insulin
AU2001258550A1 (en)	2001-11-26	Insulin formulation for inhalation
AU2002215114A1 (en)	2002-06-11	Pharmaceutical compositions for inhalation
AU2002240942A1 (en)	2002-10-21	Improved delivery of benefit agents
AU2002308649A1 (en)	2002-11-18	Compositions and methods for enhancing drug delivery
AU2002334123A1 (en)	2003-04-22	Anaesthetic compositions and method for their administration
AU2003284786A1 (en)	2004-06-23	Microemulsion composition for oral administration of biphenyldimethyldicarboxylate
AU2002354460A1 (en)	2003-07-09	Medicinal composition
EP1526838B8 (en)	2013-02-06	Intravenous pharmaceutical form of administration
AU2002315287A1 (en)	2002-10-28	Pharmaceutical composition comprising clavulanic acid
AU2002346223A1 (en)	2003-05-15	Medicinal compositions
AU2001290947A1 (en)	2002-09-24	Compositions for drug delivery